International consensus establishes a registry to evaluate treatment effectiveness in pyoderma gangrenosum, suggesting improved patient outcomes.
This international consensus establishes a standardized framework for collecting real-world data on PG. The resulting registry will serve as a critical resource for evaluating treatment effectiveness, understanding disease progression, and improving patient outcomes. It will also support future clinical trials, guideline development, quality improvement initiatives, and global patient recruitment efforts.
No takes yet. Share an insight, caveat, or question.
Haddadin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: